Trump Administration Demands Pharma Companies Begin Drug Price Negotiations, a Day After Key Deadline

Trump administration demands pharma companies begin drug price negotiations, a day after key deadline

Pharmaceutical companies say they're waiting for more details on Trump's executive order tying U.S. drug prices to those paid in other countries.

CMS Offers New Details on Medicare Drug Price Negotiations, 340B Advocates Raise Concerns About Impact on Program - 340B Report

Although the Centers for Medicare and Medicaid Services (CMS) this week released additional information to help drug manufacturers, pharmacies and other stakeholders navigate the retrospective payment process under the Inflation Reduction Act’s (IRA) Medicare Drug Price Negotiation Program, some 340B advocates said it’s not fully clear how it will work with 340B claims and raised serious concerns about the processes laid out in draft guidance.